Acer Therapeutics Inc (ACER) is down 8.77% Tuesday In Premarket Trading

Tuesday, September 05, 2023 06:53 AM | InvestorsObserver Analysts

Mentioned in this article

Acer Therapeutics Inc (ACER) is down 8.77% Tuesday In Premarket Trading

Acer Therapeutics Inc (ACER) is down Tuesday morning, with the stock declining -8.77% in pre-market trading to 1.04. ACER's short-term technical score of 44 indicates that the stock has traded less bullishly over the last month than 56% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, ACER ranks higher than 66% of stocks. Acer Therapeutics Inc has risen 50.00% over the past month, closing at $0.76 on August 8. During this period of time, the stock fell as low as $0.57 and as high as $1.76. ACER has an average analyst recommendation of Strong Buy. The company has an average price target of $9.67.

ACER has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on ACER!

See Full ACER Report

Acer Therapeutics Inc has a Long-Term Technical rank of 48. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 52% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, ACER ranks better than 132% of stocks.

Important Dates for Investors in ACER:

-Acer Therapeutics Inc is set to release earnings on 2023-11-12. Over the last 12 months, the company has reported EPS of $-1.48. -We do not have a set dividend date for Acer Therapeutics Inc at this time. Click Here To Get The Full Report on Acer Therapeutics Inc (ACER)